We give you a written timeline estimate for your case before you commit.Get my quote
Is Isembyld available in Saudi Arabia? How families get Isembyld (apitegromab-mstn)
A plain answer for families in Saudi Arabia, checked against FDA, manufacturer and regulator sources.
Reviewed by the Reserve Meds clinical operations team on 13 October 2026.
Is Isembyld available in Saudi Arabia?
Isembyld (apitegromab-mstn) is an FDA-approved muscle-targeted antibody given as an add-on to SMN2-targeted treatment for spinal muscular atrophy (SMA), as an add-on. As of 13 October 2026, we found no public record that Isembyld is registered by SFDA in Saudi Arabia. The legal route is a named-patient request: the treating hospital, on your specialist's request, asks the Saudi Food and Drug Authority (SFDA) for permission to import Isembyld for one patient, using the US FDA approval as the reference. Once approved, Reserve Meds arranges supply through a US-licensed pharmaceutical wholesale partner to the hospital pharmacy. We do not prescribe. We give you a written timeline estimate for your case before you commit.
- Registration in Saudi Arabia: not found in public sources as of 13 October 2026. Your hospital confirms before filing.
- Legal route: Named-patient import request to SFDA, filed by the treating hospital.
- Who applies: a licensed Saudi hospital, on the written request of your treating consultant.
- We give you a written timeline estimate for your case before you commit.
- Medicine price: quote on request. Every case gets a written custom quote before you commit.
What Isembyld is
Isembyld (apitegromab-mstn) is made by Scholar Rock. The US FDA approved it on 11 September 2026 for spinal muscular atrophy (SMA) in adults and children 2 years of age and older who are currently receiving a survival motor neuron 2 (SMN2)-targeted treatment. It is given as an intravenous (IV) infusion, 10 mg/kg, once every 4 weeks.
Approval was based on the phase 3 SAPPHIRE trial. Isembyld is used together with existing SMA treatments, not instead of them. Your neurologist will explain the expected benefit and the monitoring plan.
At approval, a European application was still pending.
The legal route in Saudi Arabia
Because Isembyld is approved by the US FDA, a licensed Saudi hospital can ask SFDA for permission to import it for one named patient. This is often called the named-patient route.
SFDA expects the medicine to be registered with at least one reference regulator, such as the US FDA or the European Medicines Agency. The hospital signs a declaration that it takes responsibility for safe use. A licensed importer signs a declaration covering quality during transport. The patient or a legal guardian gives written consent after the treating doctor explains the benefits and risks.
A different route, SFDA's Special Access Program, is for medicines that have no reference approval anywhere, such as products still in clinical trials. It is run through SFDA's clinical trials department and usually starts with the drug's sponsor. Isembyld does not need that route because it already has FDA approval.
We did not find it in the SFDA public drugs list when we checked on 17 October 2026, so ask your hospital pharmacy to confirm the status in SFDA's system before anything is filed.
Who does what
- Your treating specialist decides whether Isembyld is right for the patient and writes the letter and prescription.
- The hospital files the request and is responsible for giving the medicine safely.
- The Saudi Food and Drug Authority (SFDA) decides whether to approve an import of an unregistered medicine.
- Scholar Rock makes Isembyld and decides where it can be supplied.
- Reserve Meds coordinates the paperwork, the US supply through our wholesale partner, shipping and updates to your family. We do not give medical advice.
Documents the hospital will usually need
- A letter from the treating specialist: diagnosis, past treatments, and why Isembyld is needed
- A prescription with the dose and how long treatment should last
- Supporting reports, such as pathology, genetic or laboratory results
- The hospital's request form and its signed declaration of responsibility
- Written consent from the patient or a legal guardian
- Proof of the US FDA approval and the US prescribing information (we can supply these)
Timeline, step by step
- Doctor's letter. Your specialist writes the clinical letter and prescription.
- Hospital request. The hospital pharmacy files the named-patient request with SFDA.
- Regulator decision. SFDA reviews the request and issues an approval or asks for more information.
- US sourcing. Our US-licensed wholesale partner supplies the medicine, and it is shipped with the right temperature controls.
- Hospital receipt. The medicine is received at the hospital pharmacy, which gives it to the patient.
The overall time is our planning estimate, not a promise. The regulator and the manufacturer set their own timelines.
What Isembyld costs
Medicine price: quote on request. Your total cost depends on the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.
How Reserve Meds helps
Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. We do not prescribe, and we do not decide what the regulator approves.
Ask about Isembyld in Saudi Arabia
Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.
Frequently asked questions
Is Isembyld approved in Saudi Arabia?
As of 13 October 2026, we found no public record that Isembyld is registered by SFDA in Saudi Arabia. At approval, a European application was still pending. We did not find it in the SFDA public drugs list when we checked on 17 October 2026, so ask your hospital pharmacy to confirm the status in SFDA's system before anything is filed.
Who applies for permission to use Isembyld in Saudi Arabia?
The treating hospital applies to the Saudi Food and Drug Authority (SFDA), on the written request of your specialist. Families do not apply on their own, and Reserve Meds does not apply for you.
How long does it take to get Isembyld in Saudi Arabia?
We give you a written timeline estimate for your case before you commit. The regulator's review time and shipping can change this.
How much does Isembyld cost?
Medicine price: quote on request. Your total cost, including shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.
Can Reserve Meds send Isembyld straight to our home?
No. Isembyld goes to the hospital pharmacy named in the regulator's approval, which then gives it to the patient. Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We are not a pharmacy.
Sources
Checked on 13 October 2026. Regulator rules change. Your hospital pharmacy confirms the current procedure before filing.
- Drugs.com: Isembyld FDA approval history (approved 11 Sep 2026; SAPPHIRE trial)
- BioPharma Dive: Scholar Rock SMA drug Isembyld wins FDA approval
- Cure SMA: FDA approves ISEMBYLD for people living with SMA (10 mg/kg IV every 4 weeks)
- PharmaKnowl: Named Patient Program in Saudi Arabia (reference regulators, hospital and importer declarations, patient consent)
- SFDA: Special Access Program (SAP) guidance, version 1.0
- Saudi Food and Drug Authority (SFDA)